InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Kotzin Brian L., 董事. Officer active across 4 companies, notably RIGEL PHARMACEUTICALS INC. In total, 9 filings have been published. History available since 19 May 2021. The latest transaction was disclosed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kotzin Brian L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
12,500 股0Common StockSEC:0000950170-24-069927:0
25,000 股0Common StockSEC:0000905148-24-001653:0
25,000 股0Common StockSEC:0001140361-23-034283:0
12,500 股0Common StockSEC:0000950170-23-028599:0
44 股Series X Preferred StockSEC:0000899243-23-000970:0
96,154 股0Common StockSEC:0000899243-22-023092:0
25,000 股0Common StockSEC:0001140361-22-020302:0
29,183 股0Common StockSEC:0000899243-21-024206:0
25,000 股0Common StockSEC:0001179110-21-005768:0
9 条申报中的 9 条
About Kotzin Brian L.
Brian L. Kotzin is a Board Member at Rigel Pharmaceuticals Inc and Progenity, Inc., where he contributes to the governance and strategic direction of the companies. As a board member, he is involved in important decision-making and overseeing operations. His experience in the pharmaceutical sector is a valuable asset.
